» Articles » PMID: 37276878

Prevalence of and Risk Factors for Microscopic and Submicroscopic Malaria Infections in Pregnancy: a Systematic Review and Meta-analysis

Abstract

Background: Malaria infections during pregnancy can cause adverse birth outcomes, yet many infections are undetected by microscopy. We aimed to describe the epidemiology of submicroscopic malaria infections in pregnant women in Asia, the Americas, and Africa using aggregated and individual participant data (IPD).

Methods: For this systematic review and meta-analysis, studies (published Jan 1, 1997 to Nov 10, 2021) with information on both microscopic and submicroscopic infections during pregnancy from Asia, the Americas, or Africa, identified in the Malaria-in-Pregnancy Library, were eligible. Studies (or subgroups or study groups) that selected participants on the basis of the presence of fever or a positive blood smear were excluded to avoid selection bias. We obtained IPD (when available) and aggregated data. Estimates of malaria transmission intensity and sulfadoxine-pyrimethamine resistance, matched by study location and year, were obtained using publicly available data. One-stage multivariable logit and multinomial models with random intercepts for study site were used in meta-analysis to assess prevalence of and risk factors for submicroscopic infections during pregnancy and at delivery. This study is registered with PROSPERO, number CRD42015027342.

Findings: The search identified 87 eligible studies, 68 (78%) of which contributed to the analyses. Of these 68 studies, 45 (66%) studies contributed IPD (48 869 participants) and 23 (34%) studies contributed aggregated data (11 863 participants). During pregnancy, median prevalence estimates were 13·5% (range 0·0-55·9, 66 substudies) for submicroscopic and 8·0% (0·0-50·6, 66 substudies) for microscopic malaria. Among women with positive Plasmodium nucleic acid amplification tests (NAATs), the median proportion of submicroscopic infections was 58·7% (range 0·0-100); this proportion was highest in the Americas (73·3%, 0·0-100), followed by Asia (67·2%, 36·4-100) and Africa (56·5%, 20·5-97·7). In individual patient data analysis, compared with women with no malaria infections, those with submicroscopic infections were more likely to present with fever in Africa (adjusted odds ratio 1·32, 95% CI 1·02-1·72; p=0·038) but not in other regions. Among women with NAAT-positive infections in Asia and the Americas, Plasmodium vivax infections were more likely to be submicroscopic than Plasmodium falciparum infections (3·69, 2·45-5·54; p<0·0001). Risk factors for submicroscopic infections among women with NAAT-positive infections in Africa included older age (age ≥30 years), multigravidity, and no HIV infection.

Interpretation: During pregnancy, submicroscopic infections are more common than microscopic infections and are associated with fever in Africa. Malaria control in pregnancy should target both microscopic and submicroscopic infections.

Funding: Bill & Melinda Gates Foundation through the Worldwide Antimalarial Resistance Network.

Citing Articles

Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A case-cohort study of 4,352 women on the Thailand-Myanmar border.

Gilder M, Saito M, Haohankhunnatham W, Ling C, Gornsawun G, Bancone G PLoS Med. 2025; 22(3):e1004529.

PMID: 40036207 PMC: 11878921. DOI: 10.1371/journal.pmed.1004529.


Dynamics of Persistent Submicroscopic and Microscopic in Pregnant Women Under Intermittent Preventive Treatment: A Study Cohort in Benin.

Jafari-Guemouri S, Degbegni R, Courtois L, Accrombessi M, Massougbodji A, Ding X Open Forum Infect Dis. 2025; 12(1):ofae762.

PMID: 39829636 PMC: 11739809. DOI: 10.1093/ofid/ofae762.


Anti-glomerular basement membrane disease complicated by malaria during pregnancy with successful maternal and fetal outcomes: a case report.

Jafry N, Butt N, Mubarak M, Akhtar S J Nephrol. 2024; 37(9):2655-2660.

PMID: 39340709 DOI: 10.1007/s40620-024-02089-1.


Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.

Cellich P, Unger H, Rogerson S, Mola G Malar J. 2024; 23(1):201.

PMID: 38970076 PMC: 11225125. DOI: 10.1186/s12936-024-05010-0.


Microheterogeneity of Transmission Shapes Submicroscopic Malaria Carriage in Coastal Tanzania.

Rapp T, Amagai K, Sinai C, Basham C, Loya M, Ngasala S J Infect Dis. 2024; 230(2):485-496.

PMID: 38781438 PMC: 11326843. DOI: 10.1093/infdis/jiae276.


References
1.
Mayor A, Menendez C, Walker P . Targeting Pregnant Women for Malaria Surveillance. Trends Parasitol. 2019; 35(9):677-686. PMC: 6708786. DOI: 10.1016/j.pt.2019.07.005. View

2.
Oakley M, Gerald N, McCutchan T, Aravind L, Kumar S . Clinical and molecular aspects of malaria fever. Trends Parasitol. 2011; 27(10):442-9. DOI: 10.1016/j.pt.2011.06.004. View

3.
Desai M, Kuile F, Nosten F, McGready R, Asamoa K, Brabin B . Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007; 7(2):93-104. DOI: 10.1016/S1473-3099(07)70021-X. View

4.
Rijken M, McGready R, Boel M, Poespoprodjo R, Singh N, Syafruddin D . Malaria in pregnancy in the Asia-Pacific region. Lancet Infect Dis. 2011; 12(1):75-88. DOI: 10.1016/S1473-3099(11)70315-2. View

5.
Moore K, Simpson J, Scoullar M, McGready R, Fowkes F . Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5(11):e1101-e1112. DOI: 10.1016/S2214-109X(17)30340-6. View